We are live on ! Find out more
ASMB icon

Assembly Biosciences

118 hedge funds and large institutions have $502M invested in Assembly Biosciences in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 44 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

11% more funds holding

Funds holding: 106118 (+12)

0.11% more ownership

Funds ownership: 7.64%7.75% (+0.11%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

27% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 44

28% less capital invested

Capital invested by funds: $700M → $502M (-$198M)

Holders
118
Holders Change
+12
Holders Change %
+11.32%
% of All Funds
2.38%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
32
Reduced
44
Closed
10
Calls
$830K
Puts
Net Calls
+$830K
Net Calls Change
+$288K
Name Holding Trade Value Shares
Change
Change in
Stake
MAM
51
Martingale Asset Management
Massachusetts
$795K +$1.01M +4,026 New
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$762K +$2.27K +9 +0.2%
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
$751K +$959K +3,808 New
CS
54
Credit Suisse
Switzerland
$746K -$304K -1,206 -24%
AA
55
ALPS Advisors
Colorado
$689K -$57.4K -228 -6%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$686K -$160K -634 -15%
HIM
57
Hillsdale Investment Management
Ontario, Canada
$620K +$791K +3,142 New
Acadian Asset Management
58
Acadian Asset Management
Massachusetts
$593K +$756K +3,003 New
DCM
59
DAFNA Capital Management
California
$585K
VFA
60
Valeo Financial Advisors
Indiana
$521K -$7.3K -29 -1%
AllianceBernstein
61
AllianceBernstein
Tennessee
$492K -$16.6K -66 -3%
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$473K
BFM
63
Boothbay Fund Management
New York
$467K -$1.66M -6,582 -74%
HS
64
HighVista Strategies
Massachusetts
$439K +$560K +2,224 New
D.E. Shaw & Co
65
D.E. Shaw & Co
New York
$435K +$556K +2,206 New
GH
66
GAM Holding
Switzerland
$396K
Los Angeles Capital Management
67
Los Angeles Capital Management
California
$395K +$504K +2,002 New
Rafferty Asset Management
68
Rafferty Asset Management
New York
$388K +$496K +1,968 New
GCP
69
GSA Capital Partners
United Kingdom
$382K +$487K +1,934 New
Bank of America
70
Bank of America
North Carolina
$381K +$109K +433 +29%
Deutsche Bank
71
Deutsche Bank
Germany
$361K +$70.8K +281 +18%
TRCT
72
Tower Research Capital (TRC)
New York
$331K +$259K +1,028 +158%
AQR Capital Management
73
AQR Capital Management
Connecticut
$325K -$2.27K -9 -0.5%
AMCA
74
Arthur M. Cohen & Associates
Illinois
$320K
Allianz Asset Management
75
Allianz Asset Management
Germany
$315K -$297K -1,180 -42%

ASMB Hedge Fund Activity: Q3 2020 in Review

118 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2020, worth a combined $502M — down 28% from $700M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ASMB positions and 10 closed out — a net gain of 12 holders — while 32 added to existing stakes and 44 trimmed.

The largest buyer was HealthCor Management, opening a new position worth an estimated $10.9M. The largest seller was Consonance Capital Management, cutting an estimated $25.3M.

  • 118 institutional investors held Assembly Biosciences (ASMB) as of Q3 2020, up from 106 in Q2 2020.
  • Funds reported $502M of Assembly Biosciences stock for Q3 2020, down 28% quarter-over-quarter.
  • 22 funds opened new Assembly Biosciences positions in Q3 2020 and 10 closed out, a net change of +12 holders.
  • The largest Assembly Biosciences buyer in Q3 2020 was HealthCor Management, an estimated $10.9M added.
  • The largest Assembly Biosciences seller in Q3 2020 was Consonance Capital Management, an estimated $25.3M sold.

Based on aggregated 13F filings for Q3 2020.